PT2/C-Luc//PGK-SB13 Citations (14)
Originally described in: De novo induction of genetically engineered brain tumors in mice using plasmid DNA.Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, Long C, Demorest ZL, Zamora EA, Low WC, SantaCruz K, Largaespada DA, Ohlfest JR Cancer Res. 2009 Jan 15. 69(2):431-9. PubMed Journal
Articles Citing PT2/C-Luc//PGK-SB13
| Articles |
|---|
| Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways. Xin B, Yamamoto M, Fujii K, Ooshio T, Chen X, Okada Y, Watanabe K, Miyokawa N, Furukawa H, Nishikawa Y. Oncogene. 2017 Sep 7;36(36):5087-5097. doi: 10.1038/onc.2017.114. Epub 2017 May 8. PubMed |
| Oncogenic Determination of a Broad Spectrum of Phenotypes of Hepatocyte-Derived Mouse Liver Tumors. Yamamoto M, Xin B, Watanabe K, Ooshio T, Fujii K, Chen X, Okada Y, Abe H, Taguchi Y, Miyokawa N, Furukawa H, Nishikawa Y. Am J Pathol. 2017 Dec;187(12):2711-2725. doi: 10.1016/j.ajpath.2017.07.022. Epub 2017 Sep 28. PubMed |
| Integration of Oncogenes via Sleeping Beauty as a Mouse Model of HPV16(+) Oral Tumors and Immunologic Control. Lin YH, Yang MC, Tseng SH, Jiang R, Yang A, Farmer E, Peng S, Henkle T, Chang YN, Hung CF, Wu TC. Cancer Immunol Res. 2018 Mar;6(3):305-319. doi: 10.1158/2326-6066.CIR-16-0358. Epub 2018 Jan 23. PubMed |
| Mouse Model for Hepatocellular Carcinoma and Cholangiocarcinoma Originated from Mature Hepatocytes. Yamamoto M, Xin B, Nishikawa Y. Methods Mol Biol. 2019;1905:221-236. doi: 10.1007/978-1-4939-8961-4_20. PubMed |
| SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial-Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model. Xu M, Wang J, Xu Z, Li R, Wang P, Shang R, Cigliano A, Ribback S, Solinas A, Pes GM, Evert K, Wang H, Song X, Zhang S, Che L, Pascale RM, Calvisi DF, Liu Q, Chen X. Cancer Res. 2019 Nov 1;79(21):5563-5574. doi: 10.1158/0008-5472.CAN-18-3750. Epub 2019 Aug 5. PubMed |
| A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. McMahon M, Contreras A, Holm M, Uechi T, Forester CM, Pang X, Jackson C, Calvert ME, Chen B, Quigley DA, Luk JM, Kelley RK, Gordan JD, Gill RM, Blanchard SC, Ruggero D. Elife. 2019 Sep 3;8. pii: 48847. doi: 10.7554/eLife.48847. PubMed |
| A Transposon-Based Mouse Model of Hepatocellular Carcinoma via Hydrodynamic Tail Vein Injection. Yu S, Vernia S. Methods Mol Biol. 2020;2164:129-143. doi: 10.1007/978-1-0716-0704-6_14. PubMed |
| Genetically Engineered Mouse Model of Brainstem High-Grade Glioma. Nunez FM, Gauss JC, Mendez FM, Haase S, Lowenstein PR, Castro MG. STAR Protoc. 2020 Nov 25;1(3):100165. doi: 10.1016/j.xpro.2020.100165. eCollection 2020 Dec 18. PubMed |
| Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice. Liu Y, Xin B, Yamamoto M, Goto M, Ooshio T, Kamikokura Y, Tanaka H, Meng L, Okada Y, Mizukami Y, Nishikawa Y. Cancer Sci. 2021 Aug;112(8):3111-3124. doi: 10.1111/cas.14996. Epub 2021 Jun 27. PubMed |
| Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. Craig AJ, Garcia-Lezana T, Ruiz de Galarreta M, Villacorta-Martin C, Kozlova EG, Martins-Filho SN, von Felden J, Ahsen ME, Bresnahan E, Hernandez-Meza G, Labgaa I, D'Avola D, Schwartz M, Llovet JM, Sia D, Thung S, Losic B, Lujambio A, Villanueva A. PLoS Genet. 2021 Jun 24;17(6):e1009589. doi: 10.1371/journal.pgen.1009589. eCollection 2021 Jun. PubMed |
| Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7-Expressing Carcinoma in the Cervicovaginal Tract. Henkle TR, Lam B, Kung YJ, Lin J, Tseng SH, Ferrall L, Xing D, Hung CF, Wu TC. Cancer Res. 2021 Sep 1;81(17):4560-4569. doi: 10.1158/0008-5472.CAN-21-0399. Epub 2021 Jul 2. PubMed |
| Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF. Chen Z, Lu T, Huang L, Wang Z, Yan Z, Guan Y, Hu W, Fan Z, Zhu P. J Clin Invest. 2021 Oct 1;131(19). pii: e148020. doi: 10.1172/JCI148020. PubMed |
| JCI20679 suppresses the proliferation of glioblastoma stem cells by activating AMPK and decreasing NFATc2 expression levels. Ando S, Kojima N, Moyama C, Fujita M, Ohta K, Ii H, Nakata S. Mol Med Rep. 2022 Jul;26(1). pii: 238. doi: 10.3892/mmr.2022.12754. Epub 2022 May 27. PubMed |
| H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models. Haase S, Banerjee K, Mujeeb AA, Hartlage CS, Nunez FM, Nunez FJ, Alghamri MS, Kadiyala P, Carney S, Barissi MN, Taher AW, Brumley EK, Thompson S, Dreyer JT, Alindogan CT, Garcia-Fabiani MB, Comba A, Venneti S, Ravikumar V, Koschmann C, Carcaboso AM, Vinci M, Rao A, Yu JS, Lowenstein PR, Castro MG. J Clin Invest. 2022 Nov 15;132(22):e154229. doi: 10.1172/JCI154229. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.